185 related articles for article (PubMed ID: 23718853)
1. Interferon-α sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-κB activation.
Liu Y; Lou G; Wu W; Shi Y; Zheng M; Chen Z
Virol J; 2013 May; 10():168. PubMed ID: 23718853
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line.
Liu Y; Lou G; Wu W; Zheng M; Shi Y; Zhao D; Chen Z
J Viral Hepat; 2011 Oct; 18(10):e439-46. PubMed ID: 21914061
[TBL] [Abstract][Full Text] [Related]
3. HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.
Liu N; Zhang J; Yang X; Jiao T; Zhao X; Li W; Zhu J; Yang P; Jin J; Peng J; Li Z; Ye X
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592528
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.
Yang JQ; Pan GD; Chu GP; Liu Z; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2008 Sep; 14(36):5564-9; discussion 5568. PubMed ID: 18810776
[TBL] [Abstract][Full Text] [Related]
5. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
6. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
7. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation.
Chung C; Park SG; Park YM; Joh JW; Jung G
Cancer Sci; 2007 Nov; 98(11):1758-66. PubMed ID: 17711513
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis.
Yen CJ; Yang ST; Chen RY; Huang W; Chayama K; Lee MH; Yang SJ; Lai HS; Yen HY; Hsiao YW; Wang JM; Lin YJ; Hung LY
J Biomed Sci; 2019 Jun; 26(1):44. PubMed ID: 31170980
[TBL] [Abstract][Full Text] [Related]
11. DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replication.
Chen QY; Liu YH; Li JH; Wang ZK; Liu JX; Yuan ZH
World J Gastroenterol; 2012 Jun; 18(22):2850-8. PubMed ID: 22719196
[TBL] [Abstract][Full Text] [Related]
12. HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO.
Lim KH; Choi HS; Park YK; Park ES; Shin GC; Kim DH; Ahn SH; Kim KH
PLoS One; 2013; 8(3):e57331. PubMed ID: 23483900
[TBL] [Abstract][Full Text] [Related]
13. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.
Huang P; Zhuang B; Zhang H; Yan H; Xiao Z; Li W; Zhang J; Tang Q; Hu K; Koeffler HP; Wang J; Yin D
Clin Cancer Res; 2015 Oct; 21(19):4420-30. PubMed ID: 26059188
[TBL] [Abstract][Full Text] [Related]
15. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
16. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells.
Zhang F; Wang Q; Ye L; Feng Y; Zhang X
J Med Virol; 2010 May; 82(6):920-8. PubMed ID: 20419804
[TBL] [Abstract][Full Text] [Related]
18. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells.
Kong F; You H; Zhao J; Liu W; Hu L; Luo W; Hu W; Tang R; Zheng K
Virol J; 2015 Nov; 12():192. PubMed ID: 26577955
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.
Li W; Miao X; Qi Z; Zeng W; Liang J; Liang Z
Virol J; 2010 Feb; 7():45. PubMed ID: 20170530
[TBL] [Abstract][Full Text] [Related]
20. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
